Literature DB >> 9447816

Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting.

R A MacLeod1, W G Dirks, Y A Reid, R J Hay, H G Drexler.   

Abstract

During routine authentication checks, we noticed untoward karyotypic similarities between late-passage stocks of the Dami megakaryocyte and HEL erythroleukemia cell lines. Genetic identity of Dami with HEL was demonstrated by DNA fingerprinting with a (gtg)5 multilocus probe and confirmed for earlier passages of Dami deposited by its originators with the ATCC. As initial passage stocks of Dami are no longer available for comparison, we investigated whether cross-contamination by HEL was more likely to have occurred during Dami's establishment or subsequently, by karyotyping currently available stocks of both cell lines for comparison with that originally reported for Dami. We found that the karyotype of current stocks of Dami overwhelmingly resembles that described in the original report, having retained at least 16/18 structural chromosome rearrangements as described therein, cf. 12/20 shared by current stocks of Dami and HEL. HEL's antecedence is shown by the retention of normal homologs of chromosomes, 6, 18, and 21--all rearranged in Dami. These results confirm the identity of current and early passage stocks of Dami and their common origin by cross-contamination with HEL which had occurred by July 1987, a year prior to publication. Thus, most, if not all, studies using Dami are likely to have employed HEL instead and may require reappraisal.

Entities:  

Mesh:

Year:  1997        PMID: 9447816     DOI: 10.1038/sj.leu.2400868

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  A bioinformatics analysis of the cell line nomenclature.

Authors:  Sirarat Sarntivijai; Alexander S Ade; Brian D Athey; David J States
Journal:  Bioinformatics       Date:  2008-10-10       Impact factor: 6.937

2.  The influence of N-linked glycosylation on the function of platelet glycoprotein VI.

Authors:  Thomas J Kunicki; Yann Cheli; Masaaki Moroi; Kenichi Furihata
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

3.  Best practices for naming, receiving, and managing cells in culture.

Authors:  Yvonne A Reid
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-10-06       Impact factor: 2.416

4.  HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.

Authors:  Liping Li; Jung-Hyun Kim; Wenyan Lu; Donna M Williams; Joseph Kim; Leslie Cope; Raajit K Rampal; Richard P Koche; Lingling Xian; Li Z Luo; Marija Vasiljevic; Daniel R Matson; Zhizhuang Joe Zhao; Ophelia Rogers; Matthew C Stubbs; Karen Reddy; Antonio-Rodriguez Romero; Bethan Psaila; Jerry L Spivak; Alison R Moliterno; Linda M S Resar
Journal:  Blood       Date:  2022-05-05       Impact factor: 25.476

5.  Genome organization and the role of centromeres in evolution of the erythroleukaemia cell line HEL.

Authors:  Ruth N Mackinnon; Meaghan Wall; Adrian Zordan; Srilakshmi Nutalapati; Bruce Mercer; Joanne Peverall; Lynda J Campbell
Journal:  Evol Med Public Health       Date:  2013-10-01

6.  Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.

Authors:  Tahlita C M Zuiverloon; Florus C de Jong; James C Costello; Dan Theodorescu
Journal:  Bladder Cancer       Date:  2018-04-26

7.  Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18.

Authors:  Michael Maher; Jeannine Diesch; Marguerite-Marie Le Pannérer; Marta Cabezón; Mar Mallo; Sara Vergara; Aleix Méndez López; Alba Mesa Tudel; Francesc Solé; Marc Sorigue; Lurdes Zamora; Isabel Granada; Marcus Buschbeck
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.